MFIM
SONM icon

Mesirow Financial Investment Management’s DNA X Inc SONM Stock Holding History

Mesirow Financial Investment Management’s Portfolio SONM Stock Details SONM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-11
Closed -$11K – 94
2021
Q2 		$11K Buy
11
+2
+22% +$2.17K 0.03% 85
2021
Q1 		$13K Buy
+9
New +$15.9K 0.04% 120

Other funds holding SONM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SFI
Susquehanna Fundamental Investments Bala Cynwyd, Pennsylvania $2.67B AUM 21.74% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
DAS
Dynamic Advisor Solutions Phoenix, Arizona $3.53B AUM 22.61% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
EL
EMFO LLC Weston, Florida $112M AUM 18.79% 1-Year Est. Return

Mesirow Financial Investment Management's SONM Position: Q3 2021 in Review

Mesirow Financial Investment Management sold out of DNA X Inc (SONM) in Q3 2021, closing a stake of 11 shares — an estimated $11K sold.

Mesirow Financial Investment Management first reported a position in SONM in Q1 2021 and held it in 2 quarters. The position peaked at $13K in Q1 2021. 11 funds tracked by Wall St. Rank hold SONM as of Q3 2021.

  • Mesirow Financial Investment Management reported no remaining DNA X Inc position as of Q3 2021 after selling out during the quarter.
  • Mesirow Financial Investment Management sold 11 DNA X Inc shares in Q3 2021, an estimated $11K.
  • Mesirow Financial Investment Management first reported a position in DNA X Inc in Q1 2021 and held it in 2 quarters.
  • Mesirow Financial Investment Management's DNA X Inc position peaked at $13K in Q1 2021.
  • 11 funds tracked by Wall St. Rank held DNA X Inc as of Q3 2021.

Based on Mesirow Financial Investment Management's 13F filing for Q3 2021, filed 20 Oct 2021.